Companies at this level ended the following year delisted, bankrupt, restated or silent 13.1% of the time, against 4.0% for companies with a clean record.
Hover or tap a dot to see the filings behind that score.
Regenerex Pharma Inc. is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense, as additional time is required to complete its financial statements, related disclosures, and audit procedures. This delay is primarily due to an ongoing internal review of certain matters raised by a company executive, as well as the need for continued coordination with the Company’s external auditors and consultation with legal counsel to ensure the accuracy and completeness of the filing. The internal review was initiated by the independent members of the Board of Directors and remains ongoing. The Company’s auditors have advised that they are unable to complete their audit procedures until sufficient progress has been made in connection with this review. The Company is working diligently to complete the internal review and to support its auditors in finalizing the audit. The Company intends to file its Form 10-K as soon as practicable following the completion of these processes. While the Company anticipates that the results of the review may lead to adjustments to previously reported financial information, it is not currently able to reasonably estimate the nature or magnitude of any such adjustments due to the ongoing status of the review
NT 10-K, filed 2026-03-30 · auditor
2026-09-04auditor changed or resigned SEC →
Regenerex Pharma Inc. is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense, as additional time is required to complete its financial statements, related disclosures, and audit procedures. This delay is primarily due to an ongoing internal review of certain matters raised by a company executive, as well as the need for continued coordination with the Company’s external auditors and consultation with legal counsel to ensure the accuracy and completeness of the filing. The internal review was initiated by the independent members of the Board of Directors and remains ongoing. The Company’s auditors have advised that they are unable to complete their audit procedures until sufficient progress has been made in connection with this review. The Company is working diligently to complete the internal review and to support its auditors in finalizing the audit. The Company intends to file its Form 10-K as soon as practicable following the completion of these processes. While the Company anticipates that the results of the review may lead to adjustments to previously reported financial information, it is not currently able to reasonably estimate the nature or magnitude of any such adjustments due to the ongoing status of the review
The registrant was unable to complete the Form 10-Q within the prescribed time period due to unanticipated delays in compiling and reconciling financial data for the quarter ended September 30, 2025. Additional time was required to obtain and verify certain information from third-party service providers necessary to ensure the accuracy and completeness of the financial statements and related disclosures
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice